Key Points
- Herbalife insider Frank Lamberti sold shares — he sold 7,937 shares on May 11 at an average price of $13.86, worth about $110,007. After the sale, he still held 171,606 shares, and the transaction reduced his ownership by 4.42%.
- Lamberti also sold a much larger block the next day — on May 12, he sold 134,982 shares at an average price of $13.50 for a total of about $1.82 million.
- Herbalife reported better-than-expected quarterly results — the company posted EPS of $0.64 versus the $0.61 consensus and revenue of $1.32 billion, up 7.8% year over year. Despite that, the stock traded down about 4.5% and analyst sentiment remains cautious with a consensus “Hold” rating.
Herbalife Ltd (NYSE:HLF - Get Free Report) insider Frank Lamberti sold 7,937 shares of the firm's stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $13.86, for a total value of $110,006.82. Following the completion of the sale, the insider directly owned 171,606 shares in the company, valued at approximately $2,378,459.16. The trade was a 4.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.
Frank Lamberti also recently made the following trade(s):
- On Tuesday, May 12th, Frank Lamberti sold 134,982 shares of Herbalife stock. The shares were sold at an average price of $13.50, for a total value of $1,822,257.00.
Herbalife Trading Down 4.5%
Shares of HLF opened at $13.02 on Thursday. Herbalife Ltd has a 12 month low of $6.62 and a 12 month high of $20.40. The stock's 50 day moving average is $15.46 and its two-hundred day moving average is $14.41. The firm has a market cap of $1.35 billion, a P/E ratio of 5.71, a PEG ratio of 0.81 and a beta of 0.98.
Herbalife (NYSE:HLF - Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.61 by $0.03. Herbalife had a negative return on equity of 41.47% and a net margin of 4.67%.The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.30 billion. During the same period last year, the company earned $0.59 earnings per share. Herbalife's quarterly revenue was up 7.8% compared to the same quarter last year. Equities research analysts forecast that Herbalife Ltd will post 2.47 EPS for the current year.
Hedge Funds Weigh In On Herbalife
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Geode Capital Management LLC lifted its position in shares of Herbalife by 1.0% in the fourth quarter. Geode Capital Management LLC now owns 2,577,634 shares of the company's stock valued at $33,231,000 after acquiring an additional 25,783 shares in the last quarter. Quantedge Capital Pte Ltd lifted its position in Herbalife by 5.2% during the fourth quarter. Quantedge Capital Pte Ltd now owns 2,249,683 shares of the company's stock worth $28,998,000 after buying an additional 111,700 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in Herbalife by 29.3% during the first quarter. Dimensional Fund Advisors LP now owns 1,877,717 shares of the company's stock worth $27,638,000 after buying an additional 425,968 shares in the last quarter. Solel Partners LP lifted its position in Herbalife by 18.7% during the second quarter. Solel Partners LP now owns 1,669,405 shares of the company's stock worth $14,390,000 after buying an additional 262,614 shares in the last quarter. Finally, Manatuck Hill Partners LLC lifted its position in Herbalife by 122.2% during the third quarter. Manatuck Hill Partners LLC now owns 1,000,000 shares of the company's stock worth $8,440,000 after buying an additional 550,000 shares in the last quarter.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on HLF. Zacks Research downgraded Herbalife from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 20th. Wall Street Zen upgraded Herbalife from a "buy" rating to a "strong-buy" rating in a research report on Saturday, April 18th. Royal Bank Of Canada decreased their target price on Herbalife from $17.00 to $16.00 and set a "sector perform" rating on the stock in a research report on Tuesday, April 28th. Citigroup restated a "buy" rating and issued a $21.00 target price (up from $17.00) on shares of Herbalife in a research report on Thursday, February 19th. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Herbalife in a research report on Friday, May 8th. Three investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Herbalife currently has a consensus rating of "Hold" and an average price target of $17.80.
Check Out Our Latest Research Report on HLF
Herbalife Company Profile
(
Get Free Report)
Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.
Founded in 1980 by Mark R.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
